OQS
SQZ

Occudo Quantitative Strategies’s SQZ Biotechnologies Company SQZ Stock Holding History

Occudo Quantitative Strategies’s Portfolio SQZ Stock Details SQZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-11,307
Closed -$36K – 1491
2022
Q2 		$36K Buy
+11,307
New +$40.7K ﹤0.01% 1084

Other funds holding SQZ

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
N
NanoDimension Woodside, California $24.7M AUM 74.01% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Occudo Quantitative Strategies's SQZ Position: Q3 2022 in Review

Occudo Quantitative Strategies sold out of SQZ Biotechnologies Company (SQZ) in Q3 2022, closing a stake of 11,307 shares — an estimated $36K sold.

Occudo Quantitative Strategies first reported a position in SQZ in Q2 2022 and held it in 1 quarter. The position peaked at $36K in Q2 2022. 48 funds tracked by Wall St. Rank hold SQZ as of Q3 2022.

  • Occudo Quantitative Strategies reported no remaining SQZ Biotechnologies Company position as of Q3 2022 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 11,307 SQZ Biotechnologies Company shares in Q3 2022, an estimated $36K.
  • Occudo Quantitative Strategies first reported a position in SQZ Biotechnologies Company in Q2 2022 and held it in 1 quarter.
  • Occudo Quantitative Strategies's SQZ Biotechnologies Company position peaked at $36K in Q2 2022.
  • 48 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q3 2022.

Based on Occudo Quantitative Strategies's 13F filing for Q3 2022, filed 14 Nov 2022.